D-0168-2025 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0168-2025 was initiated by AvKARE on Dec 4, 2024 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 1016 50-count cartons.

Recall details

Product Type
Drugs
Report Date
Jan 8, 2025
Initiation Date
Dec 4, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1016 50-count cartons

Product description

Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. NDC#: 50268-625-15.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide USA

Code information

Lot # 47101; Exp. 02/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0168-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0168-2025. Report a data issue: hello@regdatalab.com.